Secukinumab is available as an injection under the brand name Cosentyx. The price of Cosentyx can vary significantly depending on factors such as dosage, quantity, and insurance coverage.
How much does Cosentyx cost?
The out-of-pocket cost for a 30-day supply of Cosentyx can range from approximately $6,500 to $7,500 or more [1]. This cost is for the medication itself and does not include administration fees if the injection is given by a healthcare professional.
What factors influence the price of Cosentyx?
Several elements contribute to the final price of secukinumab injections:
* Dosage and Strength: Cosentyx is available in different strengths (e.g., 75 mg/0.5 mL, 150 mg/mL) and the required dosage will impact the overall cost [1].
* Quantity: The number of prefilled syringes or auto-injectors included in a package will affect the price per supply.
* Insurance Coverage: The extent of coverage provided by a patient's insurance plan is a major determinant of out-of-pocket expenses. This includes deductibles, copays, and coinsurance [2].
* Pharmacy: Prices can differ between retail pharmacies and specialty pharmacies.
* Patient Assistance Programs: Pharmaceutical companies often offer programs to help reduce costs for eligible patients [3].
Can I get financial assistance for Cosentyx?
Yes, financial assistance may be available. Novartis, the manufacturer of Cosentyx, offers a program called Cosentyx Answers that can provide support for copayments and other out-of-pocket costs for commercially insured patients [3]. Eligibility requirements apply.
What is the dosage and administration of Cosentyx?
Cosentyx is typically administered via subcutaneous injection. The initial dose and frequency depend on the condition being treated. For example, in psoriatic arthritis and ankylosing spondylitis, the starting dose is often 150 mg once weekly for five weeks, followed by 150 mg every four weeks. Some patients may benefit from a 300 mg dose [4].
Are there lower-cost alternatives to Cosentyx?
As of now, there are no generic versions of secukinumab available. Cosentyx is a biologic medication, and the development of biosimilars is a complex and lengthy process. Biosimilars are similar to biologic medications but are not exact copies. The patent exclusivity for the original biologic can influence when biosimilar versions might become available. Information on patent expiries for specific drugs can be found on sites like DrugPatentWatch.com [5].
What are the approved uses for Cosentyx?
Secukinumab (Cosentyx) is approved for the treatment of several inflammatory conditions, including plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis [4].
Sources:
[1] GoodRx
[2] Optum Rx
[3] Cosentyx Answers
[4] Cosentyx Prescribing Information
[5] DrugPatentWatch.com